PMID- 31615456 OWN - NLM STAT- MEDLINE DCOM- 20191218 LR - 20200108 IS - 1471-2458 (Electronic) IS - 1471-2458 (Linking) VI - 19 IP - 1 DP - 2019 Oct 15 TI - Smart Phone APP to Restore Optimal Weight (SPAROW): protocol for a randomised controlled trial for women with recent gestational diabetes. PG - 1287 LID - 10.1186/s12889-019-7691-3 [doi] LID - 1287 AB - BACKGROUND: Gestational diabetes (GDM) is a known risk factor for type 2 diabetes mellitus (T2DM), and women with a history of GDM have a 7-fold increased risk of developing the disease. Achieving a healthy weight post-delivery is key in reducing the risk of future diabetes in these women. The aim of this trial is to investigate the use of an interactive smartphone application (APP) to restore women to optimal weight following delivery. METHODS: This will be an open-label randomized controlled trial. Two hundred women with gestational diabetes will be randomized to receive the intervention or standard care following delivery. Participants will be reviewed at 6 weeks and 4 months post-delivery. The intervention is an APP serving as a platform for weight, diet and physical activity tracking. The APP provides 3-5 min educational videos suggesting suitable lifestyle adjustments relevant to postnatal period such as breast feeding, diet and exercise. Lastly, the APP will allow real-time interaction between users and the team of dietitians, physiotherapists and occupational therapists to encourage restoration of optimal weight. Women in the control arm will be informed about the increased risk of developing T2DM and advised to maintain a healthy weight. Primary outcome measure is the restoration of participants' booking weight if booking BMI 23 over the 4 month period. Secondary outcome measures will assess serum metabolic and inflammatory markers, quality of life via questionnaires and cost-effectiveness of the intervention at each follow-up visit. DISCUSSION: This will be the first randomised controlled trial investigating the use of a smartphone application for postpartum weight loss in women with gestational diabetes. The major ethnic groups in our study population represent the majority of ethnic groups in Asia, amongst which the prevalence of diabetes is high. If shown to be effective, this APP may be used in wider clinical settings to improve postpartum weight loss and reduce the risk of developing T2DM in these women. TRIAL REGISTRATION: This study was registered on clintrials.gov on the 30th of October 2017, under the trial registration number: NCT03324737 . FAU - Lim, Karen AU - Lim K AD - Department of Obstetrics and Gynecology, National University Hospital, National University of Singapore, Republic of Singapore. FAU - Chi, Claudia AU - Chi C AD - Department of Obstetrics and Gynecology, National University Hospital, National University of Singapore, Republic of Singapore. FAU - Chan, Shiao-Yng AU - Chan SY AD - Department of Obstetrics and Gynecology, National University Hospital, National University of Singapore, Republic of Singapore. FAU - Lim, Su Lin AU - Lim SL AD - Department of Dietetics, National University Hospital, National University of Singapore, Republic of Singapore. FAU - Ang, Siew Min AU - Ang SM AD - Department of Dietetics, National University Hospital, National University of Singapore, Republic of Singapore. FAU - Yoong, Joanne S AU - Yoong JS AD - Saw Swee Hock School of Public Health, National University of Singapore, Republic of Singapore. FAU - Tsai, Cammy AU - Tsai C AD - Department of Rehabilitation, National University Hospital, National University of Singapore, Republic of Singapore. FAU - Wong, Su Ren AU - Wong SR AD - Department of Rehabilitation, National University Hospital, National University of Singapore, Republic of Singapore. FAU - Yew, Tong Wei AU - Yew TW AD - Department of Medicine, National University Hospital, National University of Singapore, Republic of Singapore. FAU - Tai, E Shyong AU - Tai ES AD - Department of Medicine, National University Hospital, National University of Singapore, Republic of Singapore. FAU - Yong, Eu-Leong AU - Yong EL AUID- ORCID: 0000-0001-6511-770X AD - Department of Obstetrics and Gynecology, National University Hospital, National University of Singapore, Republic of Singapore. obgyel@nus.edu.sg. LA - eng SI - ClinicalTrials.gov/NCT03324737 GR - HSRGDB16Jul013/National Medical Research Council/ PT - Journal Article PT - Randomized Controlled Trial DEP - 20191015 PL - England TA - BMC Public Health JT - BMC public health JID - 100968562 SB - IM MH - Adult MH - Clinical Protocols MH - Diabetes Mellitus, Type 2/*prevention & control MH - Diabetes, Gestational/*epidemiology MH - Female MH - Humans MH - *Mobile Applications MH - Pregnancy MH - Singapore/epidemiology MH - *Smartphone MH - Weight Reduction Programs/*methods PMC - PMC6792195 OTO - NOTNLM OT - Gestational diabetes OT - Prevention OT - Randomized controlled trial OT - Smartphone application OT - Weight loss COIS- The authors declare that they have no competing interests. EDAT- 2019/10/17 06:00 MHDA- 2019/12/19 06:00 PMCR- 2019/10/15 CRDT- 2019/10/17 06:00 PHST- 2019/09/04 00:00 [received] PHST- 2019/09/25 00:00 [accepted] PHST- 2019/10/17 06:00 [entrez] PHST- 2019/10/17 06:00 [pubmed] PHST- 2019/12/19 06:00 [medline] PHST- 2019/10/15 00:00 [pmc-release] AID - 10.1186/s12889-019-7691-3 [pii] AID - 7691 [pii] AID - 10.1186/s12889-019-7691-3 [doi] PST - epublish SO - BMC Public Health. 2019 Oct 15;19(1):1287. doi: 10.1186/s12889-019-7691-3.